Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$593,729
+$305,772 QoQ
Shares Held
43,850
-8.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#179
of 626 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $593,729 | 43,850 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $287,957 | 48,073 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $339,033 | 47,285 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $713,893 | 66,844 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $766,568 | 79,191 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,098,435 | 73,770 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,133,994 | 76,005 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $893,715 | 46,718 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,212,999 | 58,599 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $1,075,754 | 57,221 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $268,817 | 18,642 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $214,639 | 12,364 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $228,661 | 9,722 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $308,933 | 11,061 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $264,093 | 7,825 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $312,902 | 8,958 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $283,428 | 9,308 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $336,786 | 10,271 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $374,981 | 12,392 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||